Cargando…
Darinaparsin Is a Multivalent Chemotherapeutic Which Induces Incomplete Stress Response with Disruption of Microtubules and Shh Signaling
Chemotherapeutics and other pharmaceuticals are common sources of cellular stress. Darinaparsin (ZIO-101) is a novel organic arsenical under evaluation as a cancer chemotherapeutic, but the drug's precise mechanism of action is unclear. Stress granule formation is an important cellular stress r...
Autores principales: | Mason, Twila A., Kolobova, Elena, Liu, Jiang, Roland, Joseph T., Chiang, Chin, Goldenring, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216988/ https://www.ncbi.nlm.nih.gov/pubmed/22110729 http://dx.doi.org/10.1371/journal.pone.0027699 |
Ejemplares similares
-
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
por: Nielsen, Torsten H., et al.
Publicado: (2013) -
Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells
por: Yuan, Bo, et al.
Publicado: (2023) -
Dimethylarsinothioyl Glutathione
as a Metabolite in
Human Multiple Myeloma Cell Lines upon Exposure to Darinaparsin
por: Yehiayan, Lucy, et al.
Publicado: (2014) -
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
por: Kim, Won-Seog, et al.
Publicado: (2023) -
Japanese subgroup analysis in the Asian phase II study of darinaparsin in
patients with relapsed or refractory peripheral T-cell lymphoma
por: Negoro, Eiju, et al.
Publicado: (2023)